KalVista and JDRF form research partnership for novel treatment of diabetic e... ( Southampton UK and New York USA 09 J...)

KalVista and JDRF form research partnership for novel treatment of diabetic eye disease

Date:1/9/2012

Southampton, UK and New York, USA 09 January 2012 - KalVista Pharmaceuticals ("KalVista") and JDRF have formed a research partnership focused on a novel approach being developed by KalVista to preserve vision and slow the progression of diabetic eye disease. Diabetic eye disease is one of the most common and most serious complications in people with type 1 diabetes (T1D). JDRF will provide up to $2.2 million in milestone-based financial support and research expertise to KalVista. The goal of this partnership is to advance KalVista's lead pre-clinical candidate, a plasma kallikrein inhibitor, into human proof-of-concept clinical trials and to generate clinical data that would highlight its potential as an entirely new approach to treat diabetic macular edema (DME). DME is a leading cause of visual loss for people with T1D that involves swelling of the retina, which can lead to blurred vision and blindness.

Plasma kallikrein is an enzyme (a serine protease) that has been identified as a potential therapeutic target in people with diabetic retinopathy. Research has shown that it contributes to increases in blood vessel leakage and thickening of the retina. Previous JDRF-funded studies led by one of KalVista's co-founders, Edward Feener, Ph.D., Associate Professor of Medicine at Harvard Medical School and Joslin Diabetes Center, demonstrated that plasma kallikrein is increased and activated in the vitreous fluid of people with DME . This data suggests that chronic activation of plasma kallikrein increases blood vessel inflammation and permeability by generating the production of a hormone called bradykinin, which causes blood vessels to dilate or enlarge. Plasma kallikrein inhibitors are believed to reduce retinal vessel leakage by suppressing the chronic and excessive production of bradykinin.

"Diabetic eye disease is a high priority research area for JDRF. Our support of Dr. Feener's academic research over the years at the Joslin Diabetes Cen
'/>"/>

Contact: Joana Casas
mcasas@jdrf.org
212-479-7560
Juvenile Diabetes Research Foundation International
Source:Eurekalert

0

GOOD

Page: 1 2
Related medicine news :

1. Embedded Mobile & M2M Device revenues to Rise to Almost $19 Billion Globally by 2014, Says Juniper Research
2. 2010 HSR Impact Award recognizes surgical safety research
3. MSU launches first anti-counterfeiting research program
4. Researchers map all the fragile sites of the yeast Saccharomyces cerevisiaes genome
5. UH Case Medical Center researchers publish promising findings for advanced cervical cancer
6. Researchers discover new way to kill pediatric brain tumors
7. Family Research Council: Planned Parenthood Report Oversexualizes Ten-Year-Olds, Undermines Parental Authority
8. Michael J. Fox Foundation Awards $1 Million to Drive Critical New Research Tools and Technologies in Parkinsons Drug Development
9. Luth Researchs IndicatorEDG(TM) Study Finds Americans Hopes of Achieving Their Dreams Are Fading
10. International Diabetes Federation awards $2 million to 9 global diabetes research projects
11. Gladstones Robert Mahley to receive Research!America advocacy award

Post Your Comments:

(Date:5/22/2012)... of liver transplants in the United States has decreased ... one reason for the decline is that harvesting livers ... of those livers end up being discarded after doctors ... transplant. Another reason livers are discarded is because of ... disease, which is associated with metabolic syndrome and high ...

(Date:5/22/2012)... at the Medical College of Wisconsin have identified novel ... damaging radiation in large groups of people potentially exposed ... triage and treatment. , The findings are published in ... John E. Baker, Ph.D., professor of surgery, biochemistry, ... is the lead author of the study. , There ...

(Date:5/22/2012)... -- The United States made no overall progress in ... report from the Governors Highway Safety Association. An ... District of Columbia indicates that there were about 4,500 ... 2010. But some individual states did see ... in other states, according to the report released Tuesday. ...

(Date:5/22/2012)... -- New Mexico has the highest rate of injury-related ... the lowest rate, according to a new report. ... while New Jersey,s is about 36 per 100,000. Overall, ... per 100,000, according to the report released by the ... Foundation. Injuries that result from accidents, violence and ...

(Date:5/22/2012)... When brain cells start oozing too much of the ... the astrocytes that normally nourish and protect them deliver ... excreted by all neurons, but rates increase with aging ... oxygen and nutrients to neurons in addition to hauling ... by excessive amyloid. , Now researchers have shown ...

Breaking Medicine News(10 mins):Health News:U.S. Liver Transplants Declining 2 Health News:No Progress in Reducing U.S. Motorcycle Deaths: Report 2 Health News:Injury-Linked Deaths Vary Widely Among States 2 Health News:Neuron-nourishing cells appear to retaliate in Alzheimer's 2

[0] U.S. Liver Transplants Declining [0] Novel biomarkers reveal evidence of radiation exposure [0] No Progress in Reducing U.S. Motorcycle Deaths: Report [0] Injury-Linked Deaths Vary Widely Among States [0] Neuron-nourishing cells appear to retaliate in Alzheimer's

... as sole finalist for the AHA-McKesson Quest for Quality ... doctors,nurses and other health professionals of the University of ... in the country --,and some of the safest, too. ... that UMHS is this year,s lone finalist,for a major ...

... BATESVILLE, Ind., July 24 Hill-Rom Holdings,Inc.,s (NYSE: ... be,issued Wednesday, August 6, 2008. You are invited to ... 7, 2008 at 8:00 a.m. EDT., Earnings Release: ... the quarter ended June 30, 2008 will be released ...

... 34.2 percent to $0.51 from $0.38 in ... second-quarter 2007 - Record diluted EPS increased 30.2 percent to $0.56 from $0.43 in, ... ... nearly $12.8 billion, - Specialty revenues increased 32.6 percent to a record of nearly ...

... Enable Nation,s Eighth Largest Healthcare, System to Enhance the Flow ... ... Patient Care, CINCINNATI, July 24 ... Healthcare,West (CHW), the nation,s eighth largest hospital system based in San,Francisco, ...

... LAKES, N.J., July 24 BD (Becton,Dickinson and Company) ... $1.868 billion for the third fiscal quarter ended June ... prior year period. This,quarter,s revenue growth rate reflects the ... overall is estimated to account,for nearly 7 percentage points ...

... ... ... Sports, Inc. today announced that BioMoGo, the world,s first,biodegradable midsole, is ... Brooks designed BioMoGo to biodegrade 50 times,faster than conventional athletic shoe ...

U-M Health System Honored by American Hospital Association for High Quality Care and Patient Safety Hill-Rom Holdings, Inc. Invites You to Join its Fiscal 2008 Third Quarter Earnings Webcast Medco Reports Record Second-Quarter 2008 GAAP Diluted EPS; Reflects Growth of 34.2 Percent; Raises and Narrows 2008 Guidance Streamline Health(R) Signs Catholic Healthcare West for Integrated Document Workflow Solutions BD Announces Results for Third Fiscal Quarter Brooks(R) Sports Launches BioMoGo Biodegradable Shoe

(Date:5/22/2012)... 22, 2012 The hospitality industry is expecting ... season set to kickoff over the Memorial Day ... hygiene standards – to the great satisfaction of ... a developer of infection prevention products. ... hygiene practices developed for the healthcare industry," said ...

(Date:5/22/2012)... (OTCBB: MSLP.OB), a nutritional supplement company focusing on ... Major League Baseball phenom Bryce Harper as a ... Harper, a 19-year-old star outfielder for ... on April 28. He previously was the Number ... after earning the 2010 Golden Spikes Award, which ...

(Date:5/22/2012)... Laboratories Inc., a specialty pharmaceutical and diagnostic company, ... proprietary diagnostic platform presented at Digestive Disease Week ... full list below) highlight Prometheus,s innovative technologies aimed ... the goal of ultimately helping to improve patient ... scientific and clinical research that offers novel solutions ...

Breaking Medicine Technology:With Busy Summer Forecast Ahead, More Hotels Are Raising Hygiene Standards, Says UMF Corporation 2 MusclePharm Signs Pro Baseball Rookie Phenom Bryce Harper As Sponsored Athlete 2 New Data Support Role of Prometheus Laboratories' Novel Assay in Optimizing IBD Treatment Management 2 New Data Support Role of Prometheus Laboratories' Novel Assay in Optimizing IBD Treatment Management 3 New Data Support Role of Prometheus Laboratories' Novel Assay in Optimizing IBD Treatment Management 4 New Data Support Role of Prometheus Laboratories' Novel Assay in Optimizing IBD Treatment Management 5 First vaccine for viral hepatitis C could become a reality 19022 1 First vaccine for viral hepatitis C could become a reality 19022 2 Is It a Cold 3F Or an Allergy 3F 80639 1 Is It a Cold 3F Or an Allergy 3F 80639 2 Axiron AE 28Testosterone 29 Topical Solution CIII Now Available in Pharmacies 15984 1 Axiron AE 28Testosterone 29 Topical Solution CIII Now Available in Pharmacies 15984 2 Axiron AE 28Testosterone 29 Topical Solution CIII Now Available in Pharmacies 15984 3 Axiron AE 28Testosterone 29 Topical Solution CIII Now Available in Pharmacies 15984 4 Axiron AE 28Testosterone 29 Topical Solution CIII Now Available in Pharmacies 15984 5 Axiron AE 28Testosterone 29 Topical Solution CIII Now Available in Pharmacies 15984 6

[0] With Busy Summer Forecast Ahead, More Hotels Are Raising Hygiene Standards, Says UMF Corporation [0] MusclePharm Signs Pro Baseball Rookie Phenom Bryce Harper As Sponsored Athlete [0] New Data Support Role of Prometheus Laboratories' Novel Assay in Optimizing IBD Treatment Management

... 13 Gene therapy to replace the,faulty CLN2 gene, ... 8-12 years, was able to slow significantly the rate ... published online ahead of,print in the May 2008 issue ... journal published by Mary Ann Liebert, Inc. The paper ...

... benefit offer ... outcome-, SAN DIEGO, May 13 AviaraDx, Inc. ... development and,validation of a new molecular biomarker, Aviara MGI(SM) ... tumor grading for the,prediction of distant disease recurrence. The ...

Other Medicine Technology:Gene Therapy Slows Progression of Fatal Neurodegenerative Disease in Children 2 AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients 2 AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients 3 AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients 4

Gene Therapy Slows Progression of Fatal Neurodegenerative Disease in Children AviaraDx Confirms That Combination of Two Molecular Biomarkers Improves Prediction of Disease Recurrence in Early Stage Breast Cancer Patients

... is pleased to offer diagnostic guide ... high-performance, InQwire guide wire provides a ... lubricious and can help improve catheter ... a wide range of configurations to ...

... Stent System is Guidant's first in a ... chromium is stronger and more radiopaque than ... can have similar strength and visibility as ... that are only .0032" thick. Thinner struts ...

... CYPHER Sirolimus-eluting Coronary Stent consists ... called "sirolimus", a controlled-release polymer, ... platform. Upon placement, sirolimus elutes ... impedes the process of neointimal ...

PT wires combine the enhanced durability of a linear elastic nitinol distal core and a highly resilient polymer tip. This provides excellent access in difficult cases involving severe tortuosity, tig...

Medicine Products:

InQwire Guide Wire Multi-Link Vision OTW Cypher Sirolimus-eluting Coronary Stent PT2MS Guide Wire (moderate support)

KalVista and JDRF form research partnership for novel treatment of diabetic e...( Southampton UK and New York USA 09 J...),Health